RxDoctor Payments Data

Stephen Erosa, DO

Pain Medicine · Yonkers, NYNPI 1760825210

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $67,946 of the $96,301 with a category attached, or 70.6%. SPR Therapeutics, Inc accounts for 93.6% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $44,578, more than ten times the $1,427 reported in 2019. Among pain medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$96,301in general payments, 2019–2025

Across 225 payments — averaging $428.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • SPR Therapeutics, Inc$90K
  • Abbott$2K
  • Spinal Simplicity, LLC$1K
  • Boston Scientific$1K
  • Bioventus LLC$855
  • Nevro Corp.$224
  • plus $861 from 11 others

What the payments were for

  • Consulting fees$67,94671%
  • Travel & lodging$19,79821%
  • Food & beverage$8,2649%
  • Education$2930%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$96,301 in reported general payments places this provider in the 95th percentile of 503 pain medicine providers in New York.

See all pain medicine providers in New York

Medicare billing

Part B allowed, 2024
$203,818
Medicare patients
343
Services billed
1,530

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Budesonide ErBudesonide21$79,073
Gabapentin256$2,258
Pregabalin35$837
Duloxetine Hcl72$495
Baclofen13$163
Tizanidine Hcl13$67
Meloxicam19$30

Paid to pharmacies, not to this prescriber.

Other pain medicine in Yonkers

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →